Clinical Trial Update: An Observational Study to Assess the Impact of Upadacitinib in Adult Hungarian Participants With Moderate to Severe Rheumatoid Arthritis (RA) in Real-World Practice

View source ↗

Summary

The document reports the completed observational study assessing the real-world impact of upadacitinib in adults with moderate-to-severe rheumatoid arthritis in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Rheumatoid Arthritis | Status: COMPLETED